Metavalis Inc. Initiates Centralizing Critical Biotech Infrastructure In The American Interior

BRANSON, Mo. - Dec. 18, 2025 - PRLog -- Metavalis Inc. a developer of advanced Lipid Nanoparticle (LNP) delivery systems and photonic computing architectures, today announced the formal adoption of its Fortress Strategy, a strategic initiative to centralize critical biotechnology research and manufacturing within the secure interior of the United States.

While the biotechnology sector has traditionally clustered in coastal hubs, Metavalis is pioneering a decentralized approach rooted in Operational Sovereignty and National Resilience. By grounding operations in the Ozark Mountain region of Hollister, Missouri, the company aims to insulate its development of The Stealth LNP 3.0 therapeutics from the logistical fragilities and security risks inherent to congested coastal corridors.

Building the Hollister Stronghold The Fortress Strategy is designed to address two escalating threats in the global bio economy supply chain fracturing and intellectual property insecurity.

"True resilience requires a new foundation," said Jordan Bekemeier, Founder of Metavalis Inc. "The traditional model of relying on fractured, globalized supply chains is a liability in the current geopolitical climate. We are building an end to end, domestic infrastructure in the American Interior secure, centralized, and protected. We aren't just developing a drug, we are securing the future of how that drug is delivered."

The Council Approach To support this vision, Metavalis has assembled a specialized advisory roster internally dubbed the "War Council" comprised of veterans from Global Manufacturing, National Defense, and Regulatory Policy.

This divergence from the standard academic-only advisory board reflects the company's dual-use focus, ensuring that its infrastructure is as robust as its chemistry.

Strategic Advantages of the Interior

Operational Security: The Ozark region offers physical stability and a discrete operational footprint for high value intellectual property development.

Dual Use Application: The secure environment supports the company's parallel development of "Project Omega," a photonic hardware architecture designed for biological simulation.

Logistical Centrality: Located in the center of the national logistics grid, the Hollister headquarters ensures rapid domestic deployment capabilities.

Metavalis Inc. continues to advance its lead programs in metabolic disease therapeutics while fortifying the physical and digital infrastructure required for the next decade of biotech innovation.

Metavalis Inc. is a Missouri based biotechnology and hardware company operating at the intersection of genomic medicine and optical computing. The company is dedicated to solving the "delivery problem" in genetic medicine through its proprietary Stealth LNP platform, supported by a distinct philosophy of operational hardness and strategic foresight.

Check Us Out On Crunchbase https://www.crunchbase.com/organization/metavalis